cyc 202 has been researched along with Benign Neoplasms, Brain in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fernandez-Espinosa, DD; Isaja, L; Marazita, MC; Morris-Hanon, O; Romorini, L; Scassa, ME; Sevlever, GE; Videla-Richardson, GA | 1 |
| Kilbride, SM; Kögel, D; Letai, AG; Loh, KP; Murphy, ÁC; Murphy, BM; Noonan, J; Prehn, JH; Schimansky, S; Weyhenmeyer, B | 1 |
2 other study(ies) available for cyc 202 and Benign Neoplasms, Brain
| Article | Year |
|---|---|
Palbociclib Effectively Halts Proliferation but Fails to Induce Senescence in Patient-Derived Glioma Stem Cells.
Topics: Apoptosis; Brain Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cellular Senescence; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Fibroblasts; Glioma; Humans; Neoplastic Stem Cells; Phenotype; Piperazines; Pyridines; Roscovitine | 2019 |
Modulation of Mcl-1 sensitizes glioblastoma to TRAIL-induced apoptosis.
Topics: Antineoplastic Agents; Apoptosis; Brain Neoplasms; Caspase 3; Caspase 8; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Synergism; Enzyme Activation; Gene Silencing; Glioblastoma; Humans; Myeloid Cell Leukemia Sequence 1 Protein; Proto-Oncogene Proteins c-bcl-2; Purines; Roscovitine; TNF-Related Apoptosis-Inducing Ligand | 2014 |